Bausch Health Companies (BHC) Total Debt (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Total Debt came in at $21.6 billion in Q2 2026, down 4.47% year-over-year from $22.6 billion in Q2 2025, and little changed quarter-over-quarter from $21.7 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Total Debt (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Total Debt across 18 years of filings, most recently posting $21.6 billion for Q2 2026.
- In Q2 2026, Total Debt fell 4.47% year-over-year to $21.6 billion; the TTM figure through Jun 2026 stood at $21.6 billion (down 4.47% YoY), while the FY2025 annual figure was $21.0 billion, down 13.37% from the prior year.
- Total Debt came in at $21.6 billion for Q2 2026 at Bausch Health Companies, roughly flat from $21.7 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $24.3 billion in Q4 2024 to a low of $21.0 billion in Q2 2023.
- Average Total Debt over 5 years is $22.1 billion, with a median of $21.9 billion recorded in 2024.
- Year-over-year, Total Debt grew 7.74% in 2023 and retreated 13.37% in 2025.
- Over 5 years, Total Debt stood at $21.2 billion in 2022, then increased by 7.74% to $22.8 billion in 2023, then grew by 6.36% to $24.3 billion in 2024, then slipped by 13.37% to $21.0 billion in 2025, then increased by 2.69% to $21.6 billion in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $21.6 billion in Q2 2026, $21.7 billion in Q1 2026, and $21.0 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 16.59 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 13.35 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 813.33 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 2.67 Bn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 21.61 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 1.34 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 301.48 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 612.05 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.61 Bn |
| Mar 31, 2026 | 21.65 Bn |
| Dec 31, 2025 | 21.04 Bn |
| Sep 30, 2025 | 21.62 Bn |
| Jun 30, 2025 | 22.62 Bn |
| Mar 31, 2025 | 21.79 Bn |
| Dec 31, 2024 | 24.29 Bn |
| Sep 30, 2024 | 21.96 Bn |
| Jun 30, 2024 | 22.11 Bn |
| Mar 31, 2024 | 22.61 Bn |
| Dec 31, 2023 | 22.84 Bn |
| Sep 30, 2023 | 22.97 Bn |
| Jun 30, 2023 | 21.00 Bn |
| Mar 31, 2023 | 21.10 Bn |
| Dec 31, 2022 | 21.20 Bn |
| Sep 30, 2022 | 21.63 Bn |
| Jun 30, 2022 | 21.96 Bn |
| Mar 31, 2022 | 23.17 Bn |
| Dec 31, 2021 | 22.65 Bn |
| Sep 30, 2021 | 22.36 Bn |